Activating killer cell immunoglobulin-like receptors 3DS1 and 2DS1 protect against developing the severe form of recurrent respiratory papillomatosis

被引:54
作者
Bonagura, Vincent R. [1 ,2 ,3 ]
Du, Zeying [5 ]
Ashouri, Elham [5 ]
Luo, Lihui [5 ]
Hatam, Lynda J. [1 ]
DeVoti, James A. [1 ]
Rosenthal, David W. [1 ,2 ,3 ]
Steinberg, Bettie M. [1 ,3 ,4 ]
Abramson, Allan L. [1 ,4 ]
Gjertson, David W. [5 ]
Reed, Elaine F. [5 ]
Rajalingam, Raja [5 ]
机构
[1] N Shore Long Isl Jewish Hlth Syst, Feinstein Inst Med Res, Manhasset, NY 11030 USA
[2] Schneider Childrens Hosp, Div Allergy & Immunol, Dept Pediat, New Hyde Pk, NY 11040 USA
[3] N Shore Long Isl Jewish Hlth Syst, Elmezzi Grad Sch Mol Med, Manhasset, NY 11030 USA
[4] Long Isl Jewish Med Ctr, Dept Otolaryngol & Communicat Disorders, New Hyde Pk, NY 11040 USA
[5] Univ Calif Los Angeles, David Geffen Sch Med, Immunogenet Ctr, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA
基金
美国国家卫生研究院;
关键词
Killer cell immunoglobulin-like receptors; Natural killer cells; Recurrent respiratory papillomatosis; Human papillomaviruses-6 and-11; HLA association; HUMAN-PAPILLOMAVIRUS; NK CELLS; KIR; EXPRESSION; HLA; GAMMA; RECOGNITION; INTERFERON; DIVERSITY; LIGAND;
D O I
10.1016/j.humimm.2009.10.009
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The polymorphic killer cell immunoglobulin-like receptors (KIR) control natural killer (NK) cell response against viral infection and tumor transformation. Here we investigated if select KIR genes are associated with recurrent respiratory papillomatosis (RRP), a rare disease of the larynx and upper airway caused by human papillomaviruses (HPV)-6/11. DNA from 66 RRP patients and 195 healthy controls were characterized for KIR and HLA gene polymorphism. Patients lacking activating KIR genes 3DS1 and 2DS1 were more common in severe RRP compared with mild-moderate RRP (78.8% vs 48.5%, p = 0.019). Further, patients carrying any of the known Susceptible HLA-DRB1/DQB1 alleles were more frequently negative for KIR3DS1 (p = 0.006), KIR2DS1 (p = 0.003) or KIR2DS5 (p = 0.004) compared with controls carrying any of these HLA allotypes. Nearly 80% of the patients with severe disease were missing the protective HLA-DQB1*0602 allele as well as both KIR3DS1 and KIR2DS1 genes. Phenotyping of papilloma-infiltrating mononuclear-cells revealed an elevated numbers of NK cells and CD57(+)CD4(+) T cells in KIR3DS1(-)KIR2DS1(-) patients compared with patients carrying either one or both of these KIRs. Our data suggest that NK cells expressing activating receptors KIR3DS1 and KIR2DS1 may be necessary to trigger an effective early immune response against HPV-infected targets to establish resistance to RRP development. Published by Elsevier Inc. on behalf of American Society for Histocompatibility and Immunogenetics.
引用
收藏
页码:212 / 219
页数:8
相关论文
共 50 条
[1]  
ABRAMSON AL, 1992, ARCH OTOLARYNGOL, V118, P25
[2]   Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors [J].
Arase, H ;
Mocarski, ES ;
Campbell, AE ;
Hill, AB ;
Lanier, LL .
SCIENCE, 2002, 296 (5571) :1323-1326
[3]   Kinetics of HPV11 DNA replication after infection of keratinocytes with virions [J].
Auborn, KJ ;
Wang, H ;
Vaccariello, MA ;
Taichman, LB .
VIRUS RESEARCH, 1996, 43 (01) :85-90
[4]   Role of amino acid position 70 in the binding affinity of p50.1 and p58.1 receptors for HLA-Cw4 molecules [J].
Biassoni, R ;
Pessino, A ;
Malaspina, A ;
Cantoni, C ;
Bottino, C ;
Sivori, S ;
Moretta, L ;
Moretta, A .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (12) :3095-3099
[5]   NK cells and NKT cells in innate defense against viral infections [J].
Biron, CA ;
Brossay, L .
CURRENT OPINION IN IMMUNOLOGY, 2001, 13 (04) :458-464
[6]   HLA alleles, IFN-γ responses to HPV-11 E6, and disease severity in patients with recurrent respiratory papillomatosis [J].
Bonagura, VR ;
Vambutas, A ;
DeVoti, JA ;
Rosenthal, DW ;
Steinberg, BM ;
Abramson, AL ;
Shikowitz, MJ ;
Gjertson, DW ;
Reed, EF .
HUMAN IMMUNOLOGY, 2004, 65 (08) :773-782
[7]   COMMON VARIABLE HYPOGAMMAGLOBULINEMIA, RECURRENT PNEUMOCYSTIS-CARINII PNEUMONIA ON INTRAVENOUS GAMMA-GLOBULIN THERAPY, AND NATURAL-KILLER DEFICIENCY [J].
BONAGURA, VR ;
CUNNINGHAMRUNDLES, S ;
EDWARDS, BL ;
ILOWITE, NT ;
WEDGWOOD, JF ;
VALACER, DJ .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1989, 51 (02) :216-231
[8]   ENRICHED HLA-DQ3 PHENOTYPE AND DECREASED CLASS-I MAJOR HISTOCOMPATIBILITY COMPLEX ANTIGEN EXPRESSION IN RECURRENT RESPIRATORY PAPILLOMATOSIS [J].
BONAGURA, VR ;
SIEGAL, FP ;
ABRAMSON, AL ;
SANTIAGOSCHWARZ, F ;
OREILLY, ME ;
SHAH, K ;
DRAKE, D ;
STEINBERG, BM .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1994, 1 (03) :357-360
[9]   Recurrent respiratory papillomatosis:: Altered CD8+ T-cell subsets and TH1/TH2 cytokine imbalance [J].
Bonagura, VR ;
Hatam, L ;
DeVoti, J ;
Zeng, FF ;
Steinberg, BM .
CLINICAL IMMUNOLOGY, 1999, 93 (03) :302-311
[10]   Hierarchy of resistance to cervical neoplasia mediated by combinations of killer immunoglobulin-like receptor and human leukocyte antigen loci [J].
Carrington, M ;
Wang, S ;
Martin, MP ;
Gao, XJ ;
Schiffman, M ;
Cheng, J ;
Herrero, R ;
Rodriguez, AC ;
Kurman, R ;
Mortel, R ;
Schwartz, P ;
Glass, A ;
Hildesheim, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 201 (07) :1069-1075